ReviewThe oncologist2024

Long-term Outcome Analysis of Pyrotinib in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: A Real-World Study.

Xu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.